Cann Global : Placement of Remaining Entitlement Issue Shortfall

ASX release

15 OCTOBER 2020

Placement of Remaining Entitlement Issue Shortfall

Cann Global Limited (ASX: CGB) (Cann Global or the Company) is pleased to confirm that the Company has placed the remaining $859,363 balance of the shortfall under the Company's Entitlement Issue and the shortfall offer has now closed. The shortfall was placed by the Directors to existing shareholders as

well as to new investors introduced through 180 Markets, "Australia's newest Capital Raising platform with a difference".

Commenting on the placement and conclusion of the offer, CGB's Managing Director Sholom Feldman

said "We are very pleased with the level of support for the Company which has been demonstrated by our existing shareholders and are also happy to be welcoming new investors to the Register. We are excited about the prospects for the Company and look forward to sharing in the future successes of Cann Global and its businesses".

About Cann Global

Cann Global Limited (ASX:CGB) is a driving force in the hemp and medical Cannabis industries. Our strength comes from our team's core competencies and expertise, and our solid and strategic partnerships with experts in Australia, USA, Israel, Asia, Africa and Canada. We are working under the relevant legislation to ensure that the future in Medical Cannabis and Natural Foods will allow medical practitioners, patients, and consumers to gain access to the right information, as well as the safest, most effective and sustainable products.

Authority and Contact Details

This announcement has been authorised for release by Sholom Feldman, Managing Director. For further information please contact Sholom Feldman, Managing Director, on [phone], or via

email [e-mail].

Cann Global Limited - ABN 18 124 873 507

Level21, 133 Castlereagh Street, Sydney NSW 2000 - Australia

Telephone: [phone]

[e-mail]

www.canngloballimited.com